These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26573415)

  • 1. Novel, Synergistic Antifungal Combinations that Target Translation Fidelity.
    Moreno-Martinez E; Vallieres C; Holland SL; Avery SV
    Sci Rep; 2015 Nov; 5():16700. PubMed ID: 26573415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
    Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
    Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Combinations of Agents Targeting Translation That Synergistically Inhibit Fungal Pathogens.
    Vallières C; Raulo R; Dickinson M; Avery SV
    Front Microbiol; 2018; 9():2355. PubMed ID: 30349511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel antifungal nonapeptide generated by combinatorial approach.
    Kumar M; Chaturvedi AK; Kavishwar A; Shukla PK; Kesarwani AP; Kundu B
    Int J Antimicrob Agents; 2005 Apr; 25(4):313-20. PubMed ID: 15784311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus.
    Faria NC; Kim JH; Gonçalves LA; Martins Mde L; Chan KL; Campbell BC
    Lett Appl Microbiol; 2011 May; 52(5):506-13. PubMed ID: 21332761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
    Li LP; Liu W; Liu H; Zhu F; Zhang DZ; Shen H; Xu Z; Qi YP; Zhang SQ; Chen SM; He LJ; Cao XJ; Huang X; Zhang JD; Yan L; An MM; Jiang YY
    PLoS One; 2015; 10(5):e0126393. PubMed ID: 25992630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal-Based Combinations That Target Protein Synthesis by Fungi.
    Vallières C; Avery SV
    Adv Microb Physiol; 2017; 70():105-121. PubMed ID: 28528646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
    Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
    Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro antifungal activity of micafungin].
    Quindós G; Eraso E; Javier Carrillo-Muñoz A; Cantón E; Pemán J
    Rev Iberoam Micol; 2009 Mar; 26(1):35-41. PubMed ID: 19463275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative treatment of fungal infections: Synergy with non-antifungal agents.
    Rossato L; Camargo Dos Santos M; Vitale RG; de Hoog S; Ishida K
    Mycoses; 2021 Mar; 64(3):232-244. PubMed ID: 33098146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
    Pfaller MA; Messer SA; Jones RN; Castanheira M
    J Antibiot (Tokyo); 2015 Sep; 68(9):556-61. PubMed ID: 25899126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal properties of peptidomimetics with an arginine-[β-(2,5,7-tri-tert-butylindol-3-yl)alanine]-arginine motif against Saccharomyces cerevisiae and Zygosaccharomyces bailii.
    Larsen CE; Larsen CJ; Franzyk H; Regenberg B
    FEMS Yeast Res; 2015 May; 15(3):. PubMed ID: 25761917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro synergisms among hydrazones, ajoeno and posaconazole against Cryptococcus spp].
    Vivas J; Alvarado P; Visbal G; Alvarez-Aular A; Ruiz E; Ledezma E
    Invest Clin; 2011 Dec; 52(4):312-22. PubMed ID: 22523841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.